Form 4 Filing for Cellectar Biosciences, Inc. - Officer Stock Option Grant

This filing details a Form 4 submission by Kolean Chad J, CFO of Cellectar Biosciences, Inc. (CLRB). On July 7, 2026, Kolean Chad J was granted 92,000 stock options with a purchase price of $0.00, subject to stockholder approval of the amended 2021 Stock Incentive Plan, which was obtained on the same date. These options are exercisable and will vest over a three-year period starting May 28, 2026. The options are for the purchase of common stock. Post-transaction, Kolean Chad J holds 92,000 shares. The filing also notes an exercise price of $3.14 for the underlying shares, with an expiration date of May 28, 2036. This transaction is classified as an acquisition of securities by an officer.